[在骨质疏松症中使用抗吸收疗法]
Konstantin Horas1,2,3, Andreas Kurth4,5
1Orthopädisches Zentrum für Muskuloskelettale Forschung, Universität Würzburg, Brettreichstr. 11, 97074, Würzburg, Deutschland. konstantin.horas@uni-wuerzburg.de.
骨质疏松症导致骨密度低和骨质恶化,增加骨折风险. 抗吸收疗法,如双酸盐和丹诺苏马布,有助于改善骨强度和减少患者骨折.
科学领域:
- 骨生物学和骨疾病.
背景情况:
- 骨质疏松症是一种全身骨疾病,其特点是骨矿物质密度低 (BMD) 和骨组织恶化.
- 这导致骨微架构受损,骨强度受损,骨折风险增加.
研究的目的:
- 审查用于增加骨强度和减少骨质疏松症骨折风险的抗吸收疗法.
主要方法:
- 在骨质疏松症治疗中使用的常见抗吸收药物的审查.
主要成果:
- 常见的抗吸收疗法包括双酸盐,雌激素,选择性雌激素受体调节剂 (SERM) 和丹诺苏马布 (一种针对RANKL的人类单克隆抗体).
结论:
- 抗吸收疗法对于通过增强骨强度和减轻骨折风险来控制骨质疏松症至关重要.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
07:03A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
相关概念视频
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Antihypertensive Drugs: Direct Renin Inhibitors
